Shuttle extends interim CEO Cooper's consulting agreement through August 1, 2026

Shuttle Pharmaceuticals Holdings, Inc.

Extended consulting agreement with Number 2 Capital Corp. (owned by interim co-CEO Cooper) to August 1, 2026.
Monthly compensation unchanged at $20,000; 40-hour work week.
Amendment effective retroactively to September 11, 2025.
Agreement can be terminated by either party upon 30 days' notice.
Standard confidentiality and non-disclosure provisions included.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.